Mohammad B. Najib, Pharm.D., BCPS, describes the pathophysiology of Neuroleptic Malignant Syndrome (NMS), lists risk factors involved in the disease process, identifies the diagnostic criteria and an overview of the signs and symptoms, and examines management and treatment options. 

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.